Microbiota of the upper respiratory tract in children with chronic adenoiditis
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of...
Ausführliche Beschreibung
Autor*in: |
Irina V. Andriyanova [verfasserIn] Natalya A. Ilyenkova [verfasserIn] Sergey G. Vakhrushev [verfasserIn] Natalia Iu. Romanova [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Russisch |
Erschienen: |
2024 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Consilium Medicum - ZAO "Consilium Medicum", 2018, 25(2024), 12, Seite 834-837 |
---|---|
Übergeordnetes Werk: |
volume:25 ; year:2024 ; number:12 ; pages:834-837 |
Links: |
Link aufrufen |
---|
DOI / URN: |
10.26442/20751753.2024.12.202570 |
---|
Katalog-ID: |
DOAJ09717436X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ09717436X | ||
003 | DE-627 | ||
005 | 20240413174220.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2024 xx |||||o 00| ||rus c | ||
024 | 7 | |a 10.26442/20751753.2024.12.202570 |2 doi | |
035 | |a (DE-627)DOAJ09717436X | ||
035 | |a (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a rus | ||
050 | 0 | |a R5-920 | |
050 | 0 | |a RM1-950 | |
100 | 0 | |a Irina V. Andriyanova |e verfasserin |4 aut | |
245 | 1 | 0 | |a Microbiota of the upper respiratory tract in children with chronic adenoiditis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. | ||
650 | 4 | |a adenoiditis | |
650 | 4 | |a biofilms | |
650 | 4 | |a gas chromatography with mass spectrometry | |
650 | 4 | |a microbial markers | |
650 | 4 | |a pharyngeal tonsil hypertrophy | |
650 | 4 | |a upper respiratory tract microbiota | |
653 | 0 | |a Medicine (General) | |
653 | 0 | |a Therapeutics. Pharmacology | |
700 | 0 | |a Natalya A. Ilyenkova |e verfasserin |4 aut | |
700 | 0 | |a Sergey G. Vakhrushev |e verfasserin |4 aut | |
700 | 0 | |a Natalia Iu. Romanova |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Consilium Medicum |d ZAO "Consilium Medicum", 2018 |g 25(2024), 12, Seite 834-837 |w (DE-627)176059587X |x 25422170 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:12 |g pages:834-837 |
856 | 4 | 0 | |u https://doi.org/10.26442/20751753.2024.12.202570 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 |z kostenfrei |
856 | 4 | 0 | |u https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2075-1753 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2542-2170 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 12 |h 834-837 |
author_variant |
i v a iva n a i nai s g v sgv n i r nir |
---|---|
matchkey_str |
article:25422170:2024----::irboafhupreprtrtatnhlrnih |
hierarchy_sort_str |
2024 |
callnumber-subject-code |
R |
publishDate |
2024 |
allfields |
10.26442/20751753.2024.12.202570 doi (DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 DE-627 ger DE-627 rakwb rus R5-920 RM1-950 Irina V. Andriyanova verfasserin aut Microbiota of the upper respiratory tract in children with chronic adenoiditis 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology Natalya A. Ilyenkova verfasserin aut Sergey G. Vakhrushev verfasserin aut Natalia Iu. Romanova verfasserin aut In Consilium Medicum ZAO "Consilium Medicum", 2018 25(2024), 12, Seite 834-837 (DE-627)176059587X 25422170 nnns volume:25 year:2024 number:12 pages:834-837 https://doi.org/10.26442/20751753.2024.12.202570 kostenfrei https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 kostenfrei https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 kostenfrei https://doaj.org/toc/2075-1753 Journal toc kostenfrei https://doaj.org/toc/2542-2170 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2024 12 834-837 |
spelling |
10.26442/20751753.2024.12.202570 doi (DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 DE-627 ger DE-627 rakwb rus R5-920 RM1-950 Irina V. Andriyanova verfasserin aut Microbiota of the upper respiratory tract in children with chronic adenoiditis 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology Natalya A. Ilyenkova verfasserin aut Sergey G. Vakhrushev verfasserin aut Natalia Iu. Romanova verfasserin aut In Consilium Medicum ZAO "Consilium Medicum", 2018 25(2024), 12, Seite 834-837 (DE-627)176059587X 25422170 nnns volume:25 year:2024 number:12 pages:834-837 https://doi.org/10.26442/20751753.2024.12.202570 kostenfrei https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 kostenfrei https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 kostenfrei https://doaj.org/toc/2075-1753 Journal toc kostenfrei https://doaj.org/toc/2542-2170 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2024 12 834-837 |
allfields_unstemmed |
10.26442/20751753.2024.12.202570 doi (DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 DE-627 ger DE-627 rakwb rus R5-920 RM1-950 Irina V. Andriyanova verfasserin aut Microbiota of the upper respiratory tract in children with chronic adenoiditis 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology Natalya A. Ilyenkova verfasserin aut Sergey G. Vakhrushev verfasserin aut Natalia Iu. Romanova verfasserin aut In Consilium Medicum ZAO "Consilium Medicum", 2018 25(2024), 12, Seite 834-837 (DE-627)176059587X 25422170 nnns volume:25 year:2024 number:12 pages:834-837 https://doi.org/10.26442/20751753.2024.12.202570 kostenfrei https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 kostenfrei https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 kostenfrei https://doaj.org/toc/2075-1753 Journal toc kostenfrei https://doaj.org/toc/2542-2170 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2024 12 834-837 |
allfieldsGer |
10.26442/20751753.2024.12.202570 doi (DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 DE-627 ger DE-627 rakwb rus R5-920 RM1-950 Irina V. Andriyanova verfasserin aut Microbiota of the upper respiratory tract in children with chronic adenoiditis 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology Natalya A. Ilyenkova verfasserin aut Sergey G. Vakhrushev verfasserin aut Natalia Iu. Romanova verfasserin aut In Consilium Medicum ZAO "Consilium Medicum", 2018 25(2024), 12, Seite 834-837 (DE-627)176059587X 25422170 nnns volume:25 year:2024 number:12 pages:834-837 https://doi.org/10.26442/20751753.2024.12.202570 kostenfrei https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 kostenfrei https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 kostenfrei https://doaj.org/toc/2075-1753 Journal toc kostenfrei https://doaj.org/toc/2542-2170 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2024 12 834-837 |
allfieldsSound |
10.26442/20751753.2024.12.202570 doi (DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 DE-627 ger DE-627 rakwb rus R5-920 RM1-950 Irina V. Andriyanova verfasserin aut Microbiota of the upper respiratory tract in children with chronic adenoiditis 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology Natalya A. Ilyenkova verfasserin aut Sergey G. Vakhrushev verfasserin aut Natalia Iu. Romanova verfasserin aut In Consilium Medicum ZAO "Consilium Medicum", 2018 25(2024), 12, Seite 834-837 (DE-627)176059587X 25422170 nnns volume:25 year:2024 number:12 pages:834-837 https://doi.org/10.26442/20751753.2024.12.202570 kostenfrei https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 kostenfrei https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 kostenfrei https://doaj.org/toc/2075-1753 Journal toc kostenfrei https://doaj.org/toc/2542-2170 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ AR 25 2024 12 834-837 |
language |
Russian |
source |
In Consilium Medicum 25(2024), 12, Seite 834-837 volume:25 year:2024 number:12 pages:834-837 |
sourceStr |
In Consilium Medicum 25(2024), 12, Seite 834-837 volume:25 year:2024 number:12 pages:834-837 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota Medicine (General) Therapeutics. Pharmacology |
isfreeaccess_bool |
true |
container_title |
Consilium Medicum |
authorswithroles_txt_mv |
Irina V. Andriyanova @@aut@@ Natalya A. Ilyenkova @@aut@@ Sergey G. Vakhrushev @@aut@@ Natalia Iu. Romanova @@aut@@ |
publishDateDaySort_date |
2024-01-01T00:00:00Z |
hierarchy_top_id |
176059587X |
id |
DOAJ09717436X |
language_de |
russisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09717436X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413174220.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.26442/20751753.2024.12.202570</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09717436X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcae82c4827894932a40a37d514ae0ca0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Irina V. Andriyanova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microbiota of the upper respiratory tract in children with chronic adenoiditis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">adenoiditis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biofilms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gas chromatography with mass spectrometry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microbial markers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharyngeal tonsil hypertrophy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">upper respiratory tract microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalya A. Ilyenkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sergey G. Vakhrushev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalia Iu. Romanova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Consilium Medicum</subfield><subfield code="d">ZAO "Consilium Medicum", 2018</subfield><subfield code="g">25(2024), 12, Seite 834-837</subfield><subfield code="w">(DE-627)176059587X</subfield><subfield code="x">25422170</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:834-837</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.26442/20751753.2024.12.202570</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2075-1753</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2542-2170</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">12</subfield><subfield code="h">834-837</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Irina V. Andriyanova |
spellingShingle |
Irina V. Andriyanova misc R5-920 misc RM1-950 misc adenoiditis misc biofilms misc gas chromatography with mass spectrometry misc microbial markers misc pharyngeal tonsil hypertrophy misc upper respiratory tract microbiota misc Medicine (General) misc Therapeutics. Pharmacology Microbiota of the upper respiratory tract in children with chronic adenoiditis |
authorStr |
Irina V. Andriyanova |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)176059587X |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
R5-920 |
illustrated |
Not Illustrated |
issn |
25422170 |
topic_title |
R5-920 RM1-950 Microbiota of the upper respiratory tract in children with chronic adenoiditis adenoiditis biofilms gas chromatography with mass spectrometry microbial markers pharyngeal tonsil hypertrophy upper respiratory tract microbiota |
topic |
misc R5-920 misc RM1-950 misc adenoiditis misc biofilms misc gas chromatography with mass spectrometry misc microbial markers misc pharyngeal tonsil hypertrophy misc upper respiratory tract microbiota misc Medicine (General) misc Therapeutics. Pharmacology |
topic_unstemmed |
misc R5-920 misc RM1-950 misc adenoiditis misc biofilms misc gas chromatography with mass spectrometry misc microbial markers misc pharyngeal tonsil hypertrophy misc upper respiratory tract microbiota misc Medicine (General) misc Therapeutics. Pharmacology |
topic_browse |
misc R5-920 misc RM1-950 misc adenoiditis misc biofilms misc gas chromatography with mass spectrometry misc microbial markers misc pharyngeal tonsil hypertrophy misc upper respiratory tract microbiota misc Medicine (General) misc Therapeutics. Pharmacology |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Consilium Medicum |
hierarchy_parent_id |
176059587X |
hierarchy_top_title |
Consilium Medicum |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)176059587X |
title |
Microbiota of the upper respiratory tract in children with chronic adenoiditis |
ctrlnum |
(DE-627)DOAJ09717436X (DE-599)DOAJcae82c4827894932a40a37d514ae0ca0 |
title_full |
Microbiota of the upper respiratory tract in children with chronic adenoiditis |
author_sort |
Irina V. Andriyanova |
journal |
Consilium Medicum |
journalStr |
Consilium Medicum |
callnumber-first-code |
R |
lang_code |
rus |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2024 |
contenttype_str_mv |
txt |
container_start_page |
834 |
author_browse |
Irina V. Andriyanova Natalya A. Ilyenkova Sergey G. Vakhrushev Natalia Iu. Romanova |
container_volume |
25 |
class |
R5-920 RM1-950 |
format_se |
Elektronische Aufsätze |
author-letter |
Irina V. Andriyanova |
doi_str_mv |
10.26442/20751753.2024.12.202570 |
author2-role |
verfasserin |
title_sort |
microbiota of the upper respiratory tract in children with chronic adenoiditis |
callnumber |
R5-920 |
title_auth |
Microbiota of the upper respiratory tract in children with chronic adenoiditis |
abstract |
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. |
abstractGer |
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. |
abstract_unstemmed |
Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ |
container_issue |
12 |
title_short |
Microbiota of the upper respiratory tract in children with chronic adenoiditis |
url |
https://doi.org/10.26442/20751753.2024.12.202570 https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0 https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973 https://doaj.org/toc/2075-1753 https://doaj.org/toc/2542-2170 |
remote_bool |
true |
author2 |
Natalya A. Ilyenkova Sergey G. Vakhrushev Natalia Iu. Romanova |
author2Str |
Natalya A. Ilyenkova Sergey G. Vakhrushev Natalia Iu. Romanova |
ppnlink |
176059587X |
callnumber-subject |
R - General Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.26442/20751753.2024.12.202570 |
callnumber-a |
R5-920 |
up_date |
2024-07-04T00:05:21.456Z |
_version_ |
1803604744164343808 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ09717436X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413174220.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx |||||o 00| ||rus c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.26442/20751753.2024.12.202570</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ09717436X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJcae82c4827894932a40a37d514ae0ca0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">rus</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R5-920</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Irina V. Andriyanova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Microbiota of the upper respiratory tract in children with chronic adenoiditis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background. Routine application of the GC-MS method to assess the URT microbiota can potentially improve the efficacy and safety of treatment for chronic respiratory diseases. Aim. To perform a comparative analysis of the microbiota from the surface of the pharyngeal tonsil, from the deep parts of the nose, and saliva in children with chronic adenoiditis. Materials and methods. The study included 90 patients with chronic adenoiditis (CA) and/or pharyngeal tonsil hypertrophy (PTH). All study participants had swabs taken from the surface of the pharyngeal tonsil, from the deep parts of the nasal cavity, and saliva as a biological fluid of the oral cavity. Microorganisms were identified by specific fatty acids using GC-MS to assess the composition of the microbial community on the surface of the pharyngeal tonsil. Results. The study showed that the microbiota of the nasopharynx is identical in its qualitative composition to microorganisms from the deep parts of the nose. However, according to the results of the analysis of microbial markers of saliva, the oral microbiota showed significant differences in the quantitative and qualitative composition of microorganisms compared with the nasopharyngeal microbiota. Conclusion. The introduction of the GC-MS method for assessing the URT microbiota enables its monitoring in clinical practice for the treatment of chronic respiratory system diseases without disturbing the ecology of the mucous membranes and the whole body.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">adenoiditis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biofilms</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">gas chromatography with mass spectrometry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">microbial markers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharyngeal tonsil hypertrophy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">upper respiratory tract microbiota</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medicine (General)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Therapeutics. Pharmacology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalya A. Ilyenkova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sergey G. Vakhrushev</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Natalia Iu. Romanova</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Consilium Medicum</subfield><subfield code="d">ZAO "Consilium Medicum", 2018</subfield><subfield code="g">25(2024), 12, Seite 834-837</subfield><subfield code="w">(DE-627)176059587X</subfield><subfield code="x">25422170</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:12</subfield><subfield code="g">pages:834-837</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.26442/20751753.2024.12.202570</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/cae82c4827894932a40a37d514ae0ca0</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://consilium.orscience.ru/2075-1753/article/viewFile/628452/143973</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2075-1753</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2542-2170</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">12</subfield><subfield code="h">834-837</subfield></datafield></record></collection>
|
score |
7.4000463 |